Profiling of ototoxicity risk in platinum-treated children

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F19%3A00070890" target="_blank" >RIV/65269705:_____/19:00070890 - isvavai.cz</a>
Result on the web
<a href="https://link.springer.com/article/10.1007/s00210-019-01621-6" target="_blank" >https://link.springer.com/article/10.1007/s00210-019-01621-6</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Profiling of ototoxicity risk in platinum-treated children
Original language description
Cisplatin is a potent antineoplastic agent widely used for a variety of cancer types. Unfortunately, its use leads to dose limiting side effects such as ototoxicity. Up to 50% of patients receiving cisplatin will develop progressive and irreversible sensorineural hearing loss, which affects quality of life. The aim herein is to define ototoxicity risk factors.
Czech name
—
Czech description
—

Project
<a href="/en/project/7E13061" target="_blank" >7E13061: PanCare Studies in Fertility and Ototoxicity to Improve Quality of Life after Cancer during Childhood, Adolescence and Young Adulthood</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)